Zofran birth defect attorneys note that two women have filed Zofran lawsuits against GlaxoSmithKline, alleging that their Zofran use during pregnancy resulted in their babies being born with birth defects. Zofran, or ondansetron, is a prescription medication used for the prevention of vomiting and nausea in surgery and chemotherapy patients. However, it is also promoted for “off-label” use in pregnant women to help treat the symptoms of morning sickness, despite the lack of approval from the U.S. Food and Drug Administration (FDA) for this purpose.
Contact Attorney Group for information if you took Zofran during pregnancy and your child was born with birth defects. We can provide you with a free consultation, and if you have a case, we can connect you with an affiliated attorney who can file a Zofran lawsuit on your behalf.
Zofran Claims Overview
According to allegations raised by the two women, the drug maker wrongfully marketed Zofran as a treatment for morning sickness and neglected to warn the medical community and consumers about the risks of birth defects. As previously noted by Zofran birth defect lawyers, studies have linked the use of Zofran during pregnancy, particularly in the first trimester, to congenital malformations, including heart defects, cleft lip, and cleft palate.
One complaint, filed in federal court in the District of Massachusetts on February 16, 2015 was by a women claiming her daughter suffered heart defects and other malformations following the woman’s use of Zofran. According to the mother, her daughter has undergone at least 13 surgeries and continues to suffer developmental delays and other health complications.
In another complaint, filed in federal court in the Eastern District of Pennsylvania on February 12, 2015, both of the plaintiff’s children, born in 2004 and 2006 developed congenital heart defects following her use of Zofran during pregnancy. Zofran Claims against GlaxoSmithKline allege the drug maker knew or should have known about the possible relationship between birth defects and Zofran, but continued to promote Zofran for the “off-label” use in pregnant women.
In 2000, the company allegedly began to receive reports of birth defects, including 32 cases involving women who took Zofran and later gave birth to babies with bone and skeletal problems, kidney defects, stillbirth, dysmorphism, congenital heart disease and other defects. In 2012, GlaxoSmithKline agreed to a $3 billion settlement to resolve civil and criminal charges stemming from the allegedly illegal promotion and marketing of some medications, including Zofran.
Do You Have Questions About Zofran Claims?
If you or a loved one took Zofran to help treat morning sickness and delivered a child with cleft lip, cleft palate, heart defects, or other complication, contact Attorney Group to learn about your options. At no out-of-pocket cost to you, we can answer your questions. If you have a case, we can connect you with an affiliated Zofran birth defect attorney who can help you seek the compensation to which you may be entitled.
